Bone Biologics Corp Stock Alpha and Beta Analysis
| BBLGW Stock | USD 28.49 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bone Biologics Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bone Biologics over a specified time horizon. Remember, high Bone Biologics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bone Biologics' market risk premium analysis include:
Beta 1.14 | Alpha 1.17 | Risk 24.29 | Sharpe Ratio 0.0566 | Expected Return 1.37 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bone |
Bone Biologics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bone Biologics market risk premium is the additional return an investor will receive from holding Bone Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bone Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bone Biologics' performance over market.| α | 1.17 | β | 1.14 |
Bone Biologics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bone Biologics' Buy-and-hold return. Our buy-and-hold chart shows how Bone Biologics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Bone Biologics Market Price Analysis
Market price analysis indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By understating and applying Bone Biologics stock market price indicators, traders can identify Bone Biologics position entry and exit signals to maximize returns.
Bone Biologics Return and Market Media
The median price of Bone Biologics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 60.5 with a coefficient of variation of 32.02. The daily time series for the period is distributed with a sample standard deviation of 15.46, arithmetic mean of 48.3, and mean deviation of 14.79. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Bone Biologics Stock Quotes, Forecast and News Summary - Benzinga | 09/27/2024 |
2 | Acquisition by Hankey Bret of 1063830 shares of Bone Biologics subject to Rule 16b-3 | 11/01/2024 |
About Bone Biologics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bone or other stocks. Alpha measures the amount that position in Bone Biologics Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Payables Turnover | 0.001341 | 0.001274 | Days Of Inventory On Hand | 368.2 | 327.29 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bone Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bone Biologics' short interest history, or implied volatility extrapolated from Bone Biologics options trading.
Build Portfolio with Bone Biologics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Bone Stock Analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.